No Data
HAITONG SEC: The trend of moderate price reductions in the centralized procurement of Traditional Chinese Medicine varieties continues, and the domestic Pharmaceutical industry is expected to usher in a wave of mergers and acquisitions.
HAITONG SEC released a Research Report stating that the gentle trend of price reduction for Traditional Chinese Medicine varieties continues.
Modern Chinese Medicine Group Co., Ltd. (HKG:1643) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Hong Kong's Department of Health: To develop Hong Kong into a gateway for the internationalization of traditional Chinese medicine and Chinese herbal medicine.
Secretary for Food and Health of the Hong Kong Special Administrative Region, Dr. Constance Chan, stated that in order to promote the standardization and internationalization of traditional chinese medicine, Hong Kong aims to become a gateway for the internationalization of traditional chinese medicine.
Improved Revenues Required Before Modern Chinese Medicine Group Co., Ltd. (HKG:1643) Stock's 26% Jump Looks Justified
MODERN CHI MED: 2024 INTERIM REPORT
Modern Chinese Medicine Group Swings to Loss in H1
No Data
